#Intravascular Catheters Industry | Explore Tumblr posts and blogs

deshpandeisha · 2 months ago

Text

Introduction to Intravascular Temperature Management: Techniques and Benefits

The intravascular temperature management market is a rapidly growing sector in the healthcare industry, driven by the increasing demand for effective temperature management during surgical procedures and critical care settings. Intravascular temperature management involves the use of specialized catheters and devices to regulate and maintain the patient's body temperature within a desired range. This technology is particularly important in procedures such as cardiac surgeries, neurosurgeries, and post-cardiac arrest care.

he global intravascular temperature management market size was USD 290.4 Million in 2022 and is expected to register a steady revenue CAGR of 4.1% during the forecast period, according to latest analysis by Emergen Research. One of the key drivers for the intravascular temperature management market is the growing awareness of the benefits of maintaining normothermia (normal body temperature) during surgical procedures. Maintaining a stable body temperature can help reduce the risk of surgical site infections, improve patient outcomes, and shorten hospital stays. As a result, healthcare providers are increasingly adopting intravascular temperature management techniques to optimize patient care and enhance surgical outcomes.

Another driver for market growth is the increasing prevalence of chronic diseases and the aging population. Chronic conditions such as cardiovascular diseases and neurological disorders often require surgical interventions, where temperature management plays a crucial role in ensuring patient safety and recovery. Additionally, the aging population is more susceptible to temperature dysregulation, making intravascular temperature management an essential component of their care.

However, there are certain restraints that may hinder the growth of the intravascular temperature management market. One of the major challenges is the high cost associated with these devices and procedures. The initial investment, as well as the ongoing maintenance and disposable costs, can be significant for healthcare facilities. This may limit the adoption of intravascular temperature management technologies, particularly in resource-constrained settings.

In terms of recent product launches, here are a few examples:

In January 2023, ZOLL Medical Corporation introduced the Thermogard XP Intravascular Temperature Management System. This system utilizes a specialized catheter to regulate and maintain the patient's body temperature during surgical procedures and critical care. The device offers precise temperature control and real-time monitoring, enhancing patient safety and outcomes.

In March 2023, Medtronic launched the CoolGard 3000 Intravascular Cooling System. This system uses a catheter-based approach to induce therapeutic hypothermia in patients following cardiac arrest. The device helps protect the brain and other vital organs by rapidly cooling the patient's body temperature.

The report on Global Intravascular Temperature Management Market added by Emergen Research offers a comprehensive analysis of the recent advancements in the Intravascular Temperature Management industry and trends driving the growth of the market. It is an investigative study covering analysis of market drivers, restraints, challenges, threats, and growth prospects in the global Intravascular Temperature Management market. The global Intravascular Temperature Management market report is a methodical research of the Intravascular Temperature Management market done by extensive primary and secondary research. The fundamental purpose of the Intravascular Temperature Management market report is to offer an accurate and strategic analysis of the Intravascular Temperature Management business sphere.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1988

Competitive Terrain:

The global Intravascular Temperature Management industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Smith’s Group plc, The Surgical Company., EMIT CORPORATION., BD., GENTHERM., Stryker, Stihler Electronic GmbH, Belmont Medical Technologies, ZOLL Medical Corporation, and Medtronic

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Intravascular Temperature Management market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Intravascular Temperature Management market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Intravascular Temperature Management market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1988

Market Segmentations of the Intravascular Temperature Management Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Intravascular Temperature Management market on the basis of product, application, and region:

Segments Covered in this report are:

Type Outlook (Revenue, USD Million; 2019-2032)

Intravascular Cooling

Intravascular Warming

Application Outlook (Revenue, USD Million; 2019-2032)

Preoperative Care

Operative Care

Post-Operative Care

Critical Care

Intensive Care Units (ICUs)

Neurological Care Units

Emergency Rooms

Burn Centers

Others

Medical Condition Outlook (Revenue, USD Million; 2019-2032)

Stroke

Cardiac Arrest

Traumatic Brain Injury

Myocardial Infarction

Fever/ Infection

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/intravascular-temperature-management-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1988

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report: Ceramic Tiles Market | Life Science Analytics Market

0 notes

communicationblogs · 3 months ago

Text

Cardiology Surgical & Interventional Cardiology Devices Market — Forecast(2024–2030)

Cardiology Surgical & Interventional Cardiology Devices Market Overview

Interventional cardiology is a branch of cardiology that diagnoses and treats coronary artery disease, vascular disease, structural heart disease, and congenital heart defects using specialist catheter-based procedures. Interventional cardiologists utilize a variety of diagnostic equipment and imaging techniques to evaluate cardiovascular functions like blood pressure and blood flow in main arteries throughout the body as well as within the heart’s various chambers. Interventional procedures can be used to repair septal defects and patent artery ducts, balloon and stent stenosed arteries, implant artificial valves into conduits, and ablate aberrant conduction routes.

Request Sample

Intravascular ultrasonography is a catheter-based imaging method that was created to examine the vulnerability of coronary arteries and, in particular, coronary atherosclerotic plaques. Coronary intravascular ultrasound (IVUS) is increasingly important in catheterization laboratories owing to its positive prognostic impact. A ventricular assist device (VAD) is an implantable mechanical pump that helps pump blood from the lower chambers of the heart (the ventricles) to the rest of the body. A VAD (ventricular assist device) is used in people who have weakened hearts or heart failure. Optical coherence tomography imaging (OCT) is an intravascular imaging technique that allows doctors to examine a vessel’s structure at a cellular level in real-time. Coronary stents are used to treat a wide range of coronary artery disorders, including bifurcation, minor, and narrow lesions. Coronary stents have enhanced patient quality of life and clinical outcomes for all approved indications. Atherectomy devices are designed differently to either cut, shave, sand, or vaporize these plaques and have different indications. For patients, surgical and interventional cardiology devices have minimized complications and ensure a quick recovery.

The rising prevalence of cardiovascular diseases gives rise to the demand for cardiology devices and the growing advancements in technology are some of the factors driving the Cardiology Surgical & Interventional Cardiology Devices Industry forward in the projected period of 2023–2030.

Report Coverage

The report: “Cardiology Surgical & Interventional Cardiology Devices Market Forecast (2023–2030)”, by Industry ARC covers an in-depth analysis of the following segments of the Cardiology Surgical & Interventional Cardiology Devices Market.

By Product Type- Angioplasty Stents, Catheters, Plaque Modification Devices, and Others. By End-Use Industry- Hospitals, Ambulatory Surgical Centers, and Others. By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Inquiry Before Buying

Key Takeaways

Geographically, in 2021 North America held a dominant market share. It is owing to the rising development in the healthcare sector that gives rise to innovation in various technology. The market for cardiovascular medical devices in North America is increasing as the number of interventional cardiovascular cases to monitor and minimize CVDs grows. Healthcare facilities in industrialized countries such as the United States and Canada are rapidly improving and increasing the demand for cardiovascular medical equipment. These medical facilities employ cutting-edge cardiovascular medical technology to improve patient care, reduce hospital stays, and increase the quality of life. Such treatments can be conducted in outpatient settings like hospitals, ambulatory surgery centers (ASCs), and digital catheter labs owing to the development in modern healthcare settings. Therefore, an expanding number of awareness campaigns, healthcare authorities from various countries concentrate on raising diagnostic and treatment rates. This is causing a surge in medical device demand in North America. The presence of leading players focusing on product innovation and a significant portion of expenditure on research and development contributes to the regional growth.

The rising prevalence of cardiovascular diseases gives rise to the demand for cardiology devices and the growing advancements in technology are some of the factors driving the Cardiology Surgical & Interventional Cardiology Devices Market. However, the stringent government regulations on cardiovascular devices are one of the factors impeding the market growth.

A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Cardiology Surgical & Interventional Cardiology Devices Market Report.

Cardiology Surgical & Interventional Cardiology Devices Market Segmentation Analysis- By Product Type

The Cardiology Surgical & Interventional Cardiology Devices market based on product type can be further segmented into Angioplasty Stents, Catheters, Plaque Modification Devices, and Others. Catheters held a dominant market share in the year 2021. Cardiac catheterization is an imaging test that allows healthcare professionals to view a person’s blood vessels and heart by inserting a thin, flexible tube. The healthcare professional helps to perform cardiac catheterization to see how well a person’s heart is working and to diagnose any potential heart conditions. Cardiac catheterization is generally safe, with short recovery times. Cardiac catheterization is normally used to evaluate heart valves, heart function, and blood supply, as well as heart abnormalities in newborns.

However, Angioplasty Stents are estimated to be the fastest-growing, with a CAGR of 7.30% over the forecast period of 2023–2030. A technique called angioplasty is used to unblock clogged coronary arteries caused by coronary artery disease. It prevents open-heart surgery by restoring blood flow to the heart muscle. In an emergency situation, such as a heart attack, angioplasty can be performed. Angioplasty stents find applications to restore the blood flow occurring owing to blockage and reduce heart attack risks. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents help in instantly relieve or reduce the symptoms of chest pain, fatigue, and shortness of breath. Owing to such factors, the demand for stents is used in the treatment of cardiological diseases.

Cardiology Surgical & Interventional Cardiology Devices Market Segmentation Analysis- By End-Use Industry

The Cardiology Surgical & Interventional Cardiology Devices market based on the end-use industry can be further segmented into Hospitals, Ambulatory Surgical Centers, and Others. Hospitals held a dominant market share in the year 2021. In hospitals, the availability of advanced technology and skilled professionals rises owing to such factors, patients mostly prefer hospitals for their treatment and thus enhancing the market growth. In hospitals, all types of cardiovascular devices are available that help patients get the proper treatment. Moreover, owing to the rising development in the healthcare industry the number of hospitals increased which in turn escalates the demand for cardiology devices in hospitals. Also, the more modern infrastructure in hospitals gives rise to the demand for the healthcare industry which in turn accelerates the growth in the cardiology devices market.

Buy Now

However, Ambulatory Surgical Centers is estimated to be the fastest-growing, with a CAGR of 9.9% over the forecast period of 2023–2030. Ambulatory surgical centers are cost-effective, highly efficient, and offer a convenient setting for interventional cardiology procedures. In ambulatory surgical centers, the number of surgical procedures is more and owing to such factors the use of cardiology devices surges. The doctors are mostly specialized in surgical procedures and therefore patients also prefer to visit ambulatory surgical centers for their treatment. Increased adoption of technologically improved interventional cardiology equipment such as advanced cardiac catheterization devices and angioplasty stents, as well as fast-improving global healthcare infrastructure, are among the main factors driving revenue growth in this category.

Cardiology Surgical & Interventional Cardiology Devices Market Segmentation Analysis- By Geography

The Cardiology Surgical & Interventional Cardiology Devices market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. In 2021, North America held a dominant market share of 46% as compared to its other counterparts. The increasing expansion in the healthcare sector has led to technological innovation in different fields. The demand for cardiac equipment is also increasing as the number of equipment manufacturers is also growing. As the number of interventional cardiovascular cases to monitor and decrease CVDs develops in North America, the market for cardiovascular medical devices is growing. Healthcare facilities in developed countries like the United States and Canada are rapidly improving, resulting in an increase in demand for cardiovascular medical equipment. To improve patient care, shorten hospital stays, and improve quality of life, these medical facilities use cutting-edge cardiovascular medical technology. Owing to the advancements in modern healthcare, such treatments can now be performed in outpatient settings such as hospitals, ambulatory surgery centers (ASCs), and digital catheter labs. Therefore, an expanding number of awareness campaigns, healthcare authorities from various countries concentrate on raising diagnostic and treatment rates. This is causing a surge in medical device demand in North America. The presence of leading players focusing on product innovation and a significant portion of expenditure on research and development contributes to the regional growth.

Cardiology Surgical & Interventional Cardiology Devices Market Drivers

The Rising Prevalence of Cardiovascular Diseases has Readily Aided the Market Growth

Owing to the unhealthy lifestyle and increasing geriatric population, the rate of heart attacks and cardiovascular disorders has increased immensely in recent years. The most serious health disorders and the main cause of death worldwide are heart-related ailments. In both low- and middle-income nations, coronary artery disease (CAD) is one of the leading causes of illness and mortality. According to the World Health Organization in 2021, 17.9 million people worldwide die each year from cardiovascular illnesses. This accounts for 35% of all deaths worldwide. Furthermore, heart attacks and stroke account for 85 percent of all deaths from cardiovascular disease. Ischemic heart disease (IHD) is also a top cause of death worldwide, according to a Cureus Journal of Medical Science in July 2020. Ischemic heart disease affects roughly 126 million people (1,655 per 100,000), or around 1.72 percent of the world’s population. According to the British Heart Foundation, about 23 million people are suffering from coronary artery diseases in 2020, and owing to such factors, the demand for cardiology devices increases rapidly. People suffering from cardiovascular diseases or those who are at high cardiovascular risk need early detection and management. Therefore, the increasing burden of cardiovascular diseases, including coronary artery diseases, is anticipated to boost the usage of coronary stents and drive market growth.

The Growing Advancement in Technology Gives Rise to the Demand for Cardiology Devices & Interventional Cardiology Devices Market

The growing technological advancements in the areas Drug-Eluting Stents, Vascular Closure Devices, and Coronary guidewires increase the efficiency of Interventional Cardiology Devices, leading to market growth. As surgical and interventional cardiology technology advances, bare-metal stents are being phased out in favor of bioabsorbable stents. The new generation celect platinum IVC (inferior vena cava) filter is equipped with radiopaque markers to aid medical practitioners in boosting visibility during procedure imaging. The availability of advanced healthcare infrastructure, favorable government product development programs, and high levels of patient awareness, together with relatively high healthcare expenditures, pave the way for technological advancement in the interventional cardiology devices market. Market companies are competing to launch advanced products for better treatment and have spent on R&D to improve their existing goods and establish new platforms. According to the American College of Cardiology, in 2020, about 1.2 million angioplasties were performed in a year in the United States. Furthermore, the numerous advantages of minimally invasive surgeries, such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and faster recovery time, are encouraging an increasing number of patients to choose minimally invasive balloon angioplasty surgeries over traditional surgeries.

Cardiology Surgical & Interventional Cardiology Devices Market Challenges

Stringent Government Regulations for Cardiology Devices are impeding the market growth

The regulatory standards for medical device affiliation are complicated and can change as demands change. These rules are difficult to understand, particularly owing to the legal implications. Medical device quality and performance are critical aspects that must be rigorously evaluated to ensure public safety. As a result, the market’s growth is constrained by the complicated and severe rules that govern medical device affiliation. The Medical Devices Regulation seeks to ensure a high level of public health and patient safety taking into account scientific progress. According to the European Commission, there are more than 500,000 types of medical devices on the market. The new Regulation paves the way for a more patient-friendly environment, where transparency and patients’ information and choice are a priority, and patients can benefit from innovative, high-performing devices and new therapies.

Cardiology Surgical & Interventional Cardiology Devices Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cardiology Surgical & Interventional Cardiology Devices Market. The top 10- Cardiology Surgical & Interventional Cardiology Devices Market companies are-

Sinomed

Cordis

Medtronic

Abbott

Terumo Medical Corporation

C.R Bard

Boston Scientific Corporation

Biosensors International Group Ltd.

Biotronik

B. Braun Melsungen AG

#research #marketing #digital marketing #reseach marketing #healthcare #cardiology

0 notes

credenceresearchdotblog · 4 months ago

Text

The Micro Guide Catheters Market is projected to grow from USD 4,315 million in 2024 to USD 7,034.72 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.30%.The global healthcare industry continues to evolve rapidly, driven by advancements in medical technology, growing healthcare expenditure, and the increasing prevalence of chronic diseases. One of the critical components of this industry is the micro guide catheters market, which has seen significant growth over the past few years. These catheters are essential in various minimally invasive procedures, particularly in cardiovascular and neurovascular interventions, where precision and safety are paramount.

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

Market Overview

Micro guide catheters are specialized, small-diameter catheters used to navigate complex vascular pathways to deliver therapeutic agents or guide larger catheters to the target site. Their design allows for enhanced maneuverability in intricate anatomical structures, making them indispensable in procedures such as angioplasty, embolization, and stent placement.

As of 2023, the global micro guide catheters market was valued at approximately USD 500 million, with projections indicating a compound annual growth rate (CAGR) of around 7-8% over the next decade. This growth is fueled by several factors, including the rising prevalence of cardiovascular and neurovascular diseases, technological advancements, and an increasing preference for minimally invasive surgeries.

Key Growth Drivers

1. Rising Prevalence of Cardiovascular and Neurovascular Diseases: Cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for nearly 18 million deaths annually. Similarly, neurovascular diseases, including stroke and aneurysms, pose significant health risks. The growing burden of these diseases has led to a surge in demand for effective treatment options, driving the adoption of micro guide catheters in interventional procedures.

2. Technological Advancements: The development of advanced materials and innovative designs has significantly improved the performance of micro guide catheters. Innovations such as hydrophilic coatings, which reduce friction, and the use of nitinol, a superelastic metal alloy, have enhanced the flexibility, trackability, and safety of these catheters. Additionally, the integration of imaging technologies like intravascular ultrasound (IVUS) with micro guide catheters has enabled more precise navigation and positioning, further boosting their utility in complex procedures.

3. Increasing Preference for Minimally Invasive Surgeries: Minimally invasive surgeries offer numerous advantages over traditional open surgeries, including reduced recovery time, lower risk of complications, and shorter hospital stays. As a result, there has been a growing preference for these procedures among both patients and healthcare providers. Micro guide catheters, which play a crucial role in such surgeries, are thus witnessing increased demand.

4. Aging Population: The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is associated with a higher incidence of chronic conditions such as cardiovascular and neurovascular diseases, leading to a greater need for medical interventions. Consequently, the demand for micro guide catheters is expected to rise in tandem with the aging population.

Regional Market Insights

North America currently dominates the micro guide catheters market, accounting for the largest share due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and the presence of leading medical device companies. Europe follows closely, driven by the growing adoption of minimally invasive procedures and favorable reimbursement policies.

The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increasing healthcare expenditure, rising awareness about advanced treatment options, and a rapidly expanding elderly population in countries like China, Japan, and India. Additionally, the improving healthcare infrastructure in these regions is expected to provide significant growth opportunities for market players.

Competitive Landscape

The micro guide catheters market is highly competitive, with several global and regional players vying for market share. Key players include Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Cook Medical, and Asahi Intecc Co., Ltd. These companies are focusing on research and development activities to introduce innovative products and expand their product portfolios.

Strategic collaborations, mergers, and acquisitions are also common strategies adopted by market players to strengthen their market position. For instance, in 2022, Boston Scientific acquired Baylis Medical Company, a move aimed at expanding its electrophysiology and structural heart product portfolio, which includes micro guide catheters.

Future Outlook

The future of the micro guide catheters market looks promising, with continuous advancements in medical technology and the increasing adoption of minimally invasive procedures expected to drive sustained growth. However, challenges such as stringent regulatory requirements and the high cost of advanced micro guide catheters may pose barriers to market expansion.

Key Player Analysis

Covidien AG

Boston Scientific Corporation

Terumo Europe N.V.

Micro Therapeutics Inc.

Volcano Corporation

LuMend Corporation

ASAHI INTECC Company Limited

Lake Region Manufacturing Inc.

Segments:

Based on Product:

Over-the-wire Micro Guide Catheters

Flow-directed Micro Guide Catheters

Based on Application:

Cardiovascular

Neurovascular

Other Applications

Based on End User:

Hospitals/Clinics

Ambulatory Surgical Centers

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

creativeera · 5 months ago

Text

Clot Management Devices: Clot Management for Improved Treatment of Thromboembolism

The Evolution of Clot Removal Technology Clot formation inside blood vessels that supply the lungs, brain or other vital organs can have life-threatening consequences if not treated promptly and effectively. For decades, pharmacological interventions involving anticoagulant and thrombolytic drugs were the primary treatment approaches. However, these systemic therapies are not always fully successful in dissolving or removing clots, and carry risks of hemorrhage. In the past two decades, medical device technologies for minimally invasive mechanical removal or dissolution of clots have rapidly advanced. These clot management devices have revolutionized the treatment of pulmonary embolism and cerebral venous thrombosis. Catheter-Based Clot Retrieval One of the earliest and most widely used clot extraction approaches involves catheter-delivered retrievable stent designs. These devices utilize a nitinol mesh cylindrical structure that can be collapsed inside a delivery catheter and expanded upon deployment within a clot. Barbera first described use of the Tulip venous filter for retrieval of acute iliofemoral deep vein thrombosis in 1994. Building upon this, devices such as the Retrieval Inferior Vena Cava Filter and Denali Filters were developed specifically for clot capture and removal from larger veins. For pulmonary embolism, retrievable expandable stent designs like the Tulip Vena Cava Filter, Recovery Filter and OptEase Filter allowed for minimally invasive extraction of clots from the pulmonary arteries. A major advancement was the introduction of stent retrievers optimized forremoving thromboembolic occlusions from intracranial blood vessels. The Merci Retriever was among the earliest such devices approved by the FDA in 2004 for mechanical thrombectomy in acute ischemic stroke. Second generation retrievable stents like the Solitaire and Trevo devices featured superior design and deliverability profiles enabling higher recanalization rates. Recent studies support use of stent retrievers as the first-line treatment for large vessel occlusions in the anterior cerebral circulation. Ongoing research aims to expand the utility of Clot Management Devices catether-deployed devices to more distal vessel occlusions. Ultrasound-Accelerated Thrombolysis While pharmacologically-assisted thrombolysis remains a mainstay for selected patients, treatment times can be prolonged. Ultrasound energy has shown promise in accelerating fibrinolysis through mechanical fracture of clot structure and increased uptake of thrombolytic drugs. Devices generating low-frequency, high-intensity ultrasound via an intravascular catheter have been evaluated. Early studies demonstrated the EKOS System's ability to rapidly dissolve pulmonary emboli when infusing alteplase, halving treatment duration versus pharmacological therapy alone. The Sonolysis Thrombolytic Infusion Catheter was developed for treating iliofemoral deep vein thrombosis, administering ultrasound plus alteplase directly within the thrombus. More recently, the EkoSonic Endovascular System received FDA clearance for use in acute massive and submassive pulmonary embolism. Its small-profile ultrasound emitter works in tandem with front-line thrombolytic drugs to rapidly recanalize blood clots. Ongoing research also investigates combining intravascular ultrasound with novel thrombolytic drug formulations like microbubbles or plasminogen activators to potentially enhance and target fibrinolysis. Get more insights on Clot Management Devices

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

#Clot Management Devices #Thrombectomy #Blood Clot Removal #Vascular Surgery #Thrombolysis #Endovascular Devices #Stroke Treatment #Deep Vein Thrombosis #Pulmonary Embolism

0 notes

bhushans · 7 months ago

Text

A Brighter Future for Autism Care: Global Intravascular Imaging Market

Join the revolution in medical technology as the intravascular imaging market skyrockets towards unprecedented growth With a projected worth of USD 387.8 million in 2023, this dynamic sector is poised to reach an impressive USD 656.29 million by 2033.

Experience the power of innovation as the market surges forward at a remarkable Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2023 to 2033. From cutting-edge imaging technologies to groundbreaking medical advancements, the potential for transformative impact is limitless.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9926

Key Highlights:

Advancements in Imaging Technology: Ongoing advancements in intravascular imaging technology, including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), are driving market growth and innovation. These imaging modalities provide detailed visualization of blood vessel anatomy, plaque morphology, and tissue composition, enabling precise diagnosis, treatment planning, and intervention guidance in cardiovascular procedures.

Clinical Benefits and Improved Patient Outcomes: Intravascular imaging technologies offer healthcare providers valuable diagnostic information and procedural guidance, leading to improved patient outcomes and reduced procedural complications. By providing real-time visualization of vascular structures and pathology, intravascular imaging facilitates accurate lesion assessment, stent sizing, and optimization of treatment strategies, enhancing the safety and efficacy of cardiovascular interventions.

Expansion of Indications and Applications: The expanding indications and applications of intravascular imaging technologies across a wide range of cardiovascular conditions, including coronary artery disease, peripheral vascular disease, and structural heart disorders, are driving market growth. Advances in catheter design, imaging software, and data analysis algorithms are expanding the utility and versatility of intravascular imaging solutions in clinical practice.

Focus on Minimally Invasive Interventions: The shift towards minimally invasive cardiovascular interventions is driving the demand for intravascular imaging technologies that enable precise lesion characterization and treatment planning. Intravascular imaging-guided procedures such as percutaneous coronary intervention (PCI), intravascular lithotripsy (IVL), and transcatheter valve replacement (TAVR) offer patients safer, more effective alternatives to traditional open surgeries, driving market adoption and growth.

Key Takeaways:

The United States is predicted to reach US$ 700 million by 2033.

The United States is predicted to increase at a 5.6% annual rate.

The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.

China’s intravascular imaging industry is anticipated to be worthUS$850 million.

The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.

“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.

Competitive Landscape:

In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.

Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.

Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.

Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.

Segmentation Analysis of the intravascular imaging Market

By Product Type:

Instruments

Software

By Modality:

Handheld

Trolley Mounted

By End User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Long Term Care Centers

Others

By Region:

North America

Latin America

Western Europe

Eastern Europe

South Asia & Pacific

East Asia

The Middle East & Africa

0 notes

priyanshisingh · 1 year ago

Text

Intravascular Ultrasound IVUS Devices Market Analysis with Size, Revenue, Growth Drivers and Forecast to 2030

The latest market report published by Credence Research, Inc. “Global Intravascular Ultrasound IVUS Devices Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for Intravascular ultrasound IVUS devices was valued at USD 0.9 Billion in 2022 and is expected to reach USD 1.47 Billion in 2030, growing at a CAGR of 7.30% between 2023 and 2030.

The intersection of precision, diagnostic accuracy, and patient care, IVUS devices are making significant strides in improving the way medical professionals assess and treat cardiovascular diseases. In this comprehensive article, we delve into the intricacies of IVUS technology, its applications, benefits, and the transformative impact it is having on the healthcare industry.

Understanding Intravascular Ultrasound (IVUS) Devices-

IVUS Devices

IVUS devices, short for Intravascular Ultrasound devices, are cutting-edge medical tools used to visualize the interior of blood vessels with remarkable precision. These devices employ high-frequency sound waves to create detailed cross-sectional images of blood vessels from the inside. Unlike conventional imaging methods, such as X-rays or angiography, IVUS provides clinicians with a unique, real-time view of arterial walls, plaque buildup, and other structural details, enabling more accurate diagnoses and treatment decisions.

The Technology Behind IVUS

At the heart of IVUS technology is a tiny ultrasound transducer mounted on the tip of a catheter. This catheter is carefully guided into the blood vessel of interest, usually through an artery in the wrist or groin. Once inside, the transducer emits sound waves that bounce off the vessel walls and are then captured, processed, and converted into high-resolution images by a computer. The result is a live, 360-degree view of the vessel's interior, allowing physicians to assess the extent of blockages, vessel diameter, and the composition of arterial plaque.

Browse 245 pages report Intravascular Ultrasound IVUS Devices Market By Modality (Virtual Histology IVUS, iMap IVUS, Integrated Backscatter IVUS) By Product (Consoles, Accessories, Catheters, Guidewires, Others) By End-use (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030) https://www.credenceresearch.com/report/intravascular-ultrasound-ivus-device-market

Applications of IVUS Devices

Cardiovascular Disease Diagnosis

IVUS devices have become an invaluable tool in diagnosing and managing cardiovascular diseases. By providing unparalleled clarity of the arterial structures, IVUS enables healthcare professionals to detect early signs of atherosclerosis, assess stent placement, and determine the most suitable treatment strategies. This level of precision has significantly improved patient outcomes and reduced the risk of complications during cardiac interventions.

Guiding Interventional Procedures

In addition to diagnostics, IVUS plays a pivotal role in guiding interventional procedures. Whether it's angioplasty, stent placement, or atherectomy, IVUS provides real-time feedback to interventional cardiologists, ensuring optimal device positioning and deployment. This not only enhances the success rates of these procedures but also reduces the risk of complications, ultimately leading to faster patient recovery.

Advantages of IVUS Technology

Unprecedented Clarity

The clarity and detail offered by IVUS images are unmatched by any other imaging modality. This level of precision empowers healthcare providers to make informed decisions, leading to better patient outcomes and a higher standard of care.

Minimized Radiation Exposure

Unlike X-rays and CT scans, IVUS relies on ultrasound waves, eliminating the need for ionizing radiation. This reduces the risk to both patients and healthcare providers and makes IVUS a safer option, especially for those who require repeated imaging.

Enhanced Research Capabilities

IVUS devices have opened new avenues for medical research. Researchers can use IVUS to study disease progression, evaluate the effectiveness of novel therapies, and gain insights into the complex world of vascular biology.

The Future of IVUS Technology

As technology continues to advance, so does the potential of IVUS devices. Future developments may include even higher image resolution, improved catheter design for enhanced maneuverability, and integration with artificial intelligence for automated analysis of IVUS images. These advancements will further solidify IVUS as a cornerstone of modern medical practice.

Conclusion

Intravascular Ultrasound (IVUS) devices have revolutionized the way we diagnose and treat cardiovascular diseases. Their ability to provide unparalleled clarity and precision has elevated the standard of care in the medical field. As we look to the future, it's clear that IVUS technology will continue to play a pivotal role in improving patient outcomes, guiding interventions, and advancing medical research. Embracing IVUS is not just a step forward; it's a leap towards a healthier future.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Intravascular Ultrasound IVUS Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Intravascular Ultrasound IVUS Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major player analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/intravascular-ultrasound-ivus-device-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/microfluidic-modulation-spectroscopy-market

Related Report: https://www.credenceresearch.com/report/mesoporous-silica-nanoparticles-drugs-market

For More Information Browse Our Blog: https://www.linkedin.com/pulse/country-level-analysis-intravascular-ultrasound-ivus-device-dean/

Browse Our Blog: https://www.linkedin.com/pulse/intravascular-ultrasound-ivus-devices-market-analysis-priyanshi-singh

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

nitasonwane · 1 year ago

Text

Interventional Cardiology Devices Market Size, Share and Demand 2029

The interventional cardiology devices market refers to the sector of the medical device industry that focuses on devices used in the field of interventional cardiology. Interventional cardiology is a specialized branch of cardiology that involves diagnosing and treating cardiovascular diseases using minimally invasive techniques.

Interventional cardiology devices are designed to perform various procedures inside the blood vessels or heart, with the goal of diagnosing and treating conditions such as coronary artery disease, heart valve disorders, congenital heart defects, and peripheral vascular diseases. These devices are typically used in cardiac catheterization procedures, where a thin, flexible tube called a catheter is inserted into a blood vessel and guided to the heart or other relevant areas.

Some common interventional cardiology devices include:

Coronary Stents: These are small mesh-like devices used to keep narrowed or blocked coronary arteries open. They are often made of metal or a combination of metal and a drug-coated polymer

Catheters: These are thin tubes used for various purposes, such as delivering medications, removing blood clots, or performing angioplasty procedures to open blocked arteries.

Balloon Catheters: These catheters have an inflatable balloon at their tip, which can be inflated to open narrowed or blocked blood vessels. They are commonly used in angioplasty procedures.

Intravascular Ultrasound (IVUS) Systems: These devices use ultrasound technology to generate real-time images of blood vessels from inside the body. They provide detailed information about the vessel's structure and aid in guiding interventions

Embolic Protection Devices: These devices are used to capture and remove debris or blood clots that may dislodge during interventional procedures, preventing them from causing further blockages downstream.

Reduction in Number of Elective Surgeries Impeded Market Growth

The COVID-19 pandemic negatively affected the market in 2020 due to elective surgical procedures across the globe, significantly affecting the global market. According to PLOS, in September 2022, in Michigan, the total PCI procedural volume from March to December 2020 declined by 15.2% compared to 2019. In 2021, all elective and interventional surgeries were conducted in several countries across the globe. Preference for interventional procedures due to non-invasive and infection control among patients is set to propel the market growth.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them in addressing various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

0 notes

jayanthitbrc · 2 years ago

Link

0 notes

billynor · 2 years ago

Text

0 notes

marketresearchhealthcarereports · 2 months ago

Link

0 notes

markettrend24 · 2 years ago

Text

Global 2022-2028 Intravascular Catheters Industry Trends Survey and Prospects Report

Global Intravascular Catheters Market- Size, Share and Market Forecasts 2028 This report focuses on the Global Intravascular Catheters Market trends, future forecasts, growth opportunities, key end-user industries, and market players. The objectives of the study are to present the key developments of the market across the globe. Based on the Intravascular Catheters market development status,…

View On WordPress

#Coronavirus #Covid-19 #Effect of COVID-19 #Intravascular Catheters #Intravascular Catheters Forecast #Intravascular Catheters Industry #Intravascular Catheters Market #Intravascular Catheters Market CAGR Growth #Intravascular Catheters Market Opportunity #Intravascular Catheters Price #Intravascular Catheters Share #Intravascular Catheters Trends

0 notes

neha24blog · 5 years ago

Text

Intravascular Catheters Market Projected To Expand At A CAGR 11.8% For The Forecast Period 2019 To 2025 : Grand View Research Inc.

San Francisco, 28 February 2020: The Report Intravascular Catheters Market Analysis Report By Product (Short, Integrated/Closed PIVCs), By Application, By End Use (Hospitals, Clinics, ASC, Homecare), By Region, And Segment Forecasts, 2019 – 2025

The global intravascular catheters market size is expected to reach USD 8.8 billion by 2025, according to a new report by Grand View Research, Inc.,…

View On WordPress

#Intravascular Catheters Industry #Intravascular Catheters Market #Intravascular Catheters Market 2019 #Intravascular Catheters Market 2025 #Intravascular Catheters Market Revenue #Intravascular Catheters Market Share #Intravascular Catheters Market Size

0 notes

researchnesterinsights · 3 years ago

Text

Catheter Market Latest Trends, Demands and Global Outlook 2027

According to a newly published report by Research Nester on “Global Catheters Market Outlook: Industry Insights & Opportunity Assessment 2019–2027” delivers detailed overview of the global catheters market in terms of market segmentation by technology and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

In the past few decades, urology, cardiovascular and neurology diseases have become the most dominant cause of mortality and morbidity. Rising cases of diabetes, cardiovascular disorders (CVDs), urology disorders, end- stage renal disease (ESRD) and other chronic conditions due to sedentary lifestyle. Due to increasing prevalence of chronic diseases the number of surgeries performed are also increasing. Rising prevalence of chronic diseases is expected to boost the growth of the global catheters market. Rise in funding by various government bodies and medical devices manufacturers for research and development activities is estimated to boost the growth of the global catheters market with a CAGR of 8.5% over the period 2019-2027.

The global catheters market is segmented by product, distribution channel and end use. By product, the cardiovascular catheters segment is anticipated to have maximum growth on account of rise in cardiovascular diseases, increase in the prevalence of heart and related diseases, expanding awareness of available cardiac devices, rise in demand for minimal invasive surgeries and government initiatives for the improvement of healthcare facilities.

The cardiovascular catheters segments is divided into electrophysiology, PTCA Balloon, Intravascular Ultrasound (IVUS) and PTA Balloon. Urology catheters segment is divided into hemodialysis, peritoneal, foley, intermittent and external. Intravenous catheters are divided into peripheral, midline peripheral and central venous.

Further, specialty catheters are divided into wound/ surgical, oximetry, thermodilution and intrauterine insemination (IUI). The distribution channel segment is divided into hospital stores, retail stores and others. Further, the end use segment is divided into hospitals, ambulatory surgical centers and others.

Request Sample of This Strategic Report @ https://www.researchnester.com/sample-request-1665

Rising Awareness about the Product to Boost the Demand for Catheters in the Future

The global catheters market is thriving on the back of increasing awareness about catheters and the number of midscale catheter manufacturers.

Increasing number of surgeries performed– With increasing prevalence of chronic diseases, the number of catheter surgeries performed are also increasing.

North America is expected to grow at a high rate on the back of rising prevalence of cardiovascular diseases, increasing incidence of obesity, lifestyle patterns and unhealthy dietary habits and increasing geriatric population coupled with rising demand for minimally invasive procedures. Europe is expected to witness robust growth owing to growing geriatric population, increasing prevalence of diseases such as urinary disorders, neurovascular diseases and cardiac diseases and rising adoption of advanced healthcare products as well as healthcare facilities. Asia Pacific is expected to grow at a significant rate attributing to presence of population suffering from kidney and cardiovascular problems, improving medical facilities, introduction of favorable government policies and market innovations.

Request For COVID-19 Impact Insights on This Report@ https://www.researchnester.com/ask-the-analyst/rep-id-1665

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

AJ Daniel Email: [email protected] U.S. Phone: [+1 646 586 9123] U.K. Phone: [+44 203 608 591]